EXEL Archived Articles
Exelixis (EXEL): Positioning for Long-Term Growth Through Strategic Pipeline Advancements
Published on March 14, 2025
EXEL: A Resilient Oncology Powerhouse Navigating the Evolving Landscape
Published on November 30, 2024
Exelixis, Inc. (NASDAQ:EXEL): Innovative Oncology Leader Poised for Continued Growth
Published on September 24, 2024